NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UN) Receives C$6.46 Average PT from Brokerages

Shares of NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UN) have received an average rating of “Hold” from the seven ratings firms that are presently covering the firm, MarketBeat reports. Five research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The average 12-month target price among brokerages that have issued ratings on the stock in the last year is C$6.46.

Several research analysts recently issued reports on the stock. National Bankshares increased their price target on shares of NorthWest Health Prop Real Est Inv Trust from C$5.25 to C$5.75 and gave the stock a “sector perform” rating in a research report on Thursday, May 16th. CIBC lifted their target price on shares of NorthWest Health Prop Real Est Inv Trust from C$5.00 to C$5.75 and gave the company a “neutral” rating in a research note on Thursday, May 16th. Finally, BMO Capital Markets lifted their target price on shares of NorthWest Health Prop Real Est Inv Trust from C$5.00 to C$5.25 and gave the company a “market perform” rating in a research note on Monday, May 27th.

NorthWest Health Prop Real Est Inv Trust Stock Performance

TSE:NWH.UN opened at C$5.04 on Monday. NorthWest Health Prop Real Est Inv Trust has a 12-month low of C$3.89 and a 12-month high of C$7.21. The company has a quick ratio of 0.06, a current ratio of 0.19 and a debt-to-equity ratio of 128.43. The firm has a market capitalization of C$1.24 billion, a PE ratio of -4.13, a price-to-earnings-growth ratio of 0.74 and a beta of 1.05. The firm has a 50-day moving average price of C$4.91 and a 200 day moving average price of C$4.80.

About NorthWest Health Prop Real Est Inv Trust

NorthWest Healthcare Properties Real Estate Investment Trust (TSX: NWH.UN) (NorthWest) is an unincorporated, open-ended real estate investment trust established under the laws of the Province of Ontario. As at June 30, 2020, the REIT provides investors with access to a portfolio of high quality international healthcare real estate infrastructure comprised of interests in a diversified portfolio of 189 income-producing properties and 15.3 million square feet of gross leasable area located throughout major markets in Canada, Brazil, Europe, Australia and New Zealand.